Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects

Clinical and Vaccine Immunology

Volumn 15, Issue 4, 2008, Pages 585-589

  Nilsson, C ^a   Aboud, S ^b   Karlen K ^a   Hejdeman, B ^c   Urassa, W ^b   Biberfeld, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL SEPARATION; CELL VIABILITY; CELLULAR IMMUNITY; CENTRIFUGATION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PURIFICATION; RELIABILITY; SWEDEN; T LYMPHOCYTE; TANZANIA; TECHNIQUE;

CELL SEPARATION; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; SWEDEN; TANZANIA;

EID: 47049112539     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00161-07     Document Type: Article

References (23)

1. Aidoo, I., and I. Udhayakumar. 2000. Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development. Parasitol. Today 16:50-56.
2. Berzofsky, J. A., J. D. Ahlers, J. Janik, J. Morris, S. Oh, M. Terabe, and I. M. Belyakov. 2004. Progress on new vaccine strategies against chronic viral infections. J. Clin. Investig. 114:450-462.
3. + T-cells. Blood 107:4781-4789.
4. Betts, M. R., D. R. Ambrozak, D. C. Douek, S. Bonhoeffer, J. M. Brenchley, J. P. Casazza, R. A. Koup, and L. J. Picker. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4 and CD8 T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
5. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Investig. 21:77-89.
6. Bull, M., D. Lee, J. Stucky, Y.-L. Chiu, A. Rubin, H. Horton, and M. J. McElrath. 2007. Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. J. Immunol. Methods 322:57-69.
7. Cox, J. H., G. Ferrari, and S. Janetzki. 2006. Measurement of cytokine release at the single cell level using the ELISPOT assay. Methods 38:274-282.
8. Cox, J. H., M. DeSouza, S. Ratto-Kim, G. Ferrari, K. Weinhold, and D. L. Birx. 2006. Cellular immunity assays for evaluation of vaccine efficacy, p. 301-314. In B. Detrick, R. G. Hamilton, and J. D. Folds (ed.), Manual of clinical laboratory immunology, 7th ed. ASM Press, Washington, DC.
9. Currier, J. R., E. G. Kuta, E. Turk, L. B. Earhart, L. Loomis-Price, S. Janetzki, G. Ferrari, D. L. Birx, and J. H. Cox. 2002. A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J. Immunol. Methods 260:157-172.
10. Czerkinsky, C. C., A Tarkowski, L. A. Nilsson, O. Ouchterlony, H. Nygren, and C. Gretzer. 1984. Reverse enzyme-linked immunospot assay (RELISPOT) for the detection of cells secreting immunoreactive substances. J. Immunol. Methods 72:489-496.
11. Disis, M. L., C. dela Rosa, V. Goodell, L.-Y. Kuan, J. C. C. Chang, K. Kruus-Reichel, T. M. Clay, H. K. Lyerly, S. Bhatia, S. A. Ghanekar, V. C. Maino, and H. T. Maecker. 2006. Maximizing the retention of antigen specific lymphocyte function after cryopreservation. J. Immunol. Methods 308:13-18.
12. Girard, M. P., S. K. Osmanov, and M. Paule Kieny. 2006. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 24:4062-4081.
13. Hulstaert, F., I. Hannet, V. Deneys, V. Munhyeshuli, T. Reichert, M. De Bryere, and K. Strauss. 1994. Age-related changes in human blood lymphocyte populations. II. Varying kinetics of percentage and absolute cell count measurements. Clin. Immunol. Immunopathol. 70:152-158.
14. Jones, A. R., D. Twedt, W. Swain, and E. Gottfried. 1996. Diurnal change of blood count analytes in normal subjects. Am. J. Clin. Pathol. 106:723-727.
15. Kaufmann, S. H. 2002. Protection against tuberculosis: cytokines, T cells and macrophages. Ann. Rheum. Dis. 61(Suppl. 2):54-58.
16. Kern, F., G. LiPira, J. W. Gratama, F. Manca, and M. Roederer. 2005. Measuring Ag-specific immune responses: understanding immunepathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. Trends Immunol. 26:477-484.
17. Malone, J. L., T. E. Simms, G. C. Gray, K. F. Wagner, J. R. Burge, and D. S. Burke. 1990. Sources of variability in repeated T-lymphocyte counts for human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J. Aquir. Immune Defic. Syndr. 3:144-151.
18. Matee, M. I. N., P. M. Magesa, and E. F. Lyamuya. 2006. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infection among blood donors at Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health 6:21-26.
19. McMichael, A. J. 2006. HIV vaccines. Annu. Rev. Immunol. 24:227-255.
20. Roederer, M., J. M. Brenchley, M. R. Betts, and S. C. De Rosa. 2004. Flow cytometric analysis of vaccine responses: how many colors are enough? Clin. Immunol. 110:199-205.
21. Ruitenberg, J. J., C. B. Mulder, V. C. Maino, A. L. Landay, and S. A. Ghanekar. 2006. VACUTAINER CPT and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples. BMC Immunol. 7:11-18.
22. Schlenke, P., H. Klünter, M. Müller-Steinhardt, H.-J. Hammers, K. Borchert, and G. Bein. 1998. Evaluation of a novel mononuclear cell isolation procedure for serological HIV typing. Clin. Diagn. Lab. Immunol. 5:808-813.
23. Weinberg, A., L. Zhang, D. Brown, A. Erice, B. Polsky, M. S. Hirsch, S. Owens, and K. Lamb. 2000. Viability and functional activity of cryopreserved mononuclear cells. Clin. Diagn. Lab. Immunol. 7:714-716.